HIV: Trispecific antibodies block infection
Nature Reviews Drug Discovery 16, 754 (2017).
doi:10.1038/nrd.2017.208
Author: Sarah Crunkhorn
The use of broadly neutralizing antibodies (bnAbs) isolated from HIV-infected individuals in the development of an effective AIDS vaccine has been limited by potency and breadth of protection. Now, Xu et al. report the generation of multi-specific antibodies derived from bnAbs with specificities for
Source: Nature Reviews Drug Discovery - Category: Drugs & Pharmacology Authors: Sarah Crunkhorn Tags: Research Highlight Source Type: research